Reactivity to alpha agonists is heightened in immature porcine pulmonary arteries

M Kadletz1, R J Dignan, A S Wechsler

  • 1Division of Cardiothoracic Surgery, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0645, USA.

Insights

Immature pigs show less pulmonary artery constriction but enhanced alpha-receptor constriction compared to mature pigs. These findings may explain pulmonary vasoconstriction in pediatric cardiac surgery patients.

Area of Science:

  • Cardiovascular Physiology
  • Pediatric Cardiology
  • Vascular Biology

Background:

  • Pulmonary hypertension is a frequent complication following cardiopulmonary bypass in pediatric cardiac surgery.
  • Understanding developmental differences in pulmonary artery responses is crucial for managing perioperative complications.

Purpose of the Study:

  • To investigate the differences in pulmonary artery constrictor and dilator responses between adult and immature pigs.
  • To determine if age-related variations in vascular reactivity contribute to perioperative pulmonary hypertension in pediatric patients.

Main Methods:

  • Pulmonary artery ring segments from mature (15-19 weeks) and immature (4-5 weeks) pigs were analyzed using a vessel myograph.
  • Vasoconstriction was assessed using potassium chloride and phenylephrine; vasodilation was evaluated using bradykinin and acetylcholine.
  • Maximum smooth muscle relaxation was induced with sodium nitroprusside.

Main Results:

  • Endothelium- and smooth muscle-mediated vasodilation responses were similar across age groups.
  • Pulmonary artery segments from immature pigs exhibited significantly less constriction to potassium chloride compared to mature pigs.
  • Immature pigs demonstrated enhanced alpha-receptor-mediated constriction in pulmonary artery segments relative to mature pigs.

Conclusions:

  • Developmental differences in pulmonary artery smooth muscle reactivity exist, with immature pigs showing heightened alpha-adrenergic responses.
  • These findings provide a potential explanation for the occurrence of perioperative pulmonary vasoconstriction observed in pediatric cardiac surgery patients.
Abstract

Related Concept Videos

Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...